Have you recently taken and suffered strange and unexpected side effects as a result? If so, you’re not alone- a new lawsuit filed against manufacturers alleges that the company should have known about or knew about and failed to warn patients about the high risk of gastrointestinal bleeding.
The lawsuit argues that defendants Janssen Research and Development, an arm of Johnson & Johnson, should have been aware of the severe side effects that put patients at risk. No patients expect to discover that taking a medication they believe will help with a medical condition could put them at greater risk of injuries, but for plaintiff Alice Huffman of West Virginia, the dangers of the drug far outweighed the benefits.
The popular medication is often given to patients at risk of systemic embolism and stroke and for treating deep vein thrombosis. The medication was approved by the FDA in 2011 to reduce blood clot risks. This medication was initially given to patients who completed hip or knee replacement surgery. The use of the drug as approved by the FDA ultimately expanded to include patients at risk of pulmonary embolism and DVT.
According to the lawsuit, the manufacturer failed to include appropriate warnings on the box regarding gastrointestinal bleeding. The plaintiff’s lawsuit alleges that the medication was marketed in a misleading fashion. Other medications, including generic warfarin, were available for patients facing these risks.
According to the plaintiff and other consumers who have come forward after suffering from gastrointestinal bleeding, appropriate information about the risks were not provided to patients or doctors that would allow them to make an informed decision about whether was the right fit. A number of adverse event reports, including the information shared by the plaintiff in this case, note that led to instances of gastrointestinal bleeding, some of which could be life-threatening.
Huffman was given a prescription in early August 2015 for . Less than a week later, she claims she was hospitalized for gastrointestinal bleeding. Permanent injuries and life-threatening bleeding incidents are reported in the gastrointestinal bleeding lawsuit.
Like many other patients who took the drug, these consumers were not informed about the dangerous risks of side effects that might have given them cause for concern to select one of the other medications designed to treat the same medical conditions. Other options on the market do not present the high risk of gastrointestinal bleeding.
gastrointestinal bleeding may be a serious issue that could cause further medical conditions, pain and suffering, and other damages. Situations like this often form the basis of an lawsuit. Talking to an experienced lawyer is strongly recommended if you or someone you know has already suffered due to a defective or dangerous drug.
The attorneys at McDonald Worley have helped many patients bring forward lawsuits against manufacturers of dangerous drugs. Fill out the form on this page and receive a FREE case evaluation.
